EMBS

FAQs

 

Focus and Scope

JTEHM focuses on innovative solutions to healthcare needs from the biomedical engineering, clinical engineering, and medical communities that bridge the engineering and clinical worlds. JTEHM’s unique scope is original work at the intersection of engineering and clinical translation.

The journal’s scope is interdisciplinary collaborations among researchers, healthcare providers, and industry. We publish results and best practices from these translational efforts and serve as a community hub for researchers, clinicians, and developers who are addressing challenges in technology development, commercialization, and deployment for better global healthcare. Our ultimate goal is to improve the practice of engineering in translational medicine and to serve as a focal point for the nascent community. Our interactive content includes video, lively commentary, blogs, and other features to engage our clinical and engineering communities.

Topics

JTEHM publishes articles on subjects including, but not limited to, the following representative topics:

  • Medical Devices and Systems
  • Nano-biosensors and Biosystems
  • Medical Imaging and Diagnostic Radiology
  • Cardiovascular Devices and Systems
  • Neurovascular Devices and Systems
  • Rehabilitation Devices and Systems
  • Surgical and Interventional Devices
  • Bio and Surgical Robotics
  • Wearable Sensors and Health Monitoring Systems
  • Point-of-Care Technologies
  • Wireless and Communication Technologies for Bio-Information Systems
  • Electronic Medical Records and Medical Information Systems
  • Clinical Ideation
  • Clinical Trials
  • Clinical Commercialization
  • Clinical Engineering
  • Global Health
  • Harsh Environments
  • Hematology and Hemostasis
  • Metabolics
  • Oncology
  • Risk and Uncertainty
  • Social Determinants of Health
  • Law, Ethics, and Policy
  • Medicine

We welcome papers with research findings and clinical translation studies from clinicians, engineering faculty and students, industry, policy makers, and the investment community. We also welcome your input and comments on challenges in quality global healthcare, clinical needs, and issues in technology translation to clinical applications on our community forum. We encourage you to make your voice heard in the blogs and commentary sections of this website.

Is Your Article a Good Fit for JTEHM?

We are committed to accepting the highest quality papers possible and to a quick response time for our authors. If you have any question about the suitability of your work for JTEHM, send us an abstract (editors@health.embs.org). We will be happy to provide you with a quick response.

Publication Frequency

JTEHM publishes articles “continuously”; that is, articles are published online as soon as they are available (peer-reviewed and copyedited). On our website, they are subsequently collated into archival “issues” (about 4 issues per year) and “volumes” (one per year).

What is Open Access?

As an open-access journal, JTEHM is entirely free to our readers; subscription is not necessary, and authors do not cede copyright to IEEE.

Review Process

Submitted manuscripts are subject to a rigorous but speedy peer review process. We aim for a standard review time of less than 2 months. The review process is designed to help authors to improve their manuscripts by giving them constructive comments on how to improve their paper, and to publish only those articles which comply with general quality criteria of a scholarly paper, especially originality, clarity, references to related work and validity of results and conclusions. In addition, we require a translational element to the work or a clear path to clinical application.

When we receive a manuscript, the Managing Editor will first decide whether the manuscript meets the formal criteria specified in the JTEHM template and, in consultation with the Editors in Chief, whether it fits within the scope of the journal. When in doubt, the editors will consult other members of the Editorial Board. Manuscripts are then assigned to an Associate Editor, who sends each paper to 2 external experts for peer review. Authors are required to suggest at least 1 peer-reviewer (who does not have a conflict of interest) during the submission process.

Speed of Peer-Review

Bioengineering is a fast-moving field and we acknowledge the need of our authors to communicate their findings rapidly. We therefore aim to be extremely fast (but still thorough and rigorous) in our peer-review process. However, actual times needed to review and edit papers vary, and primarily depend on the quality of the paper upon first submission. Normally we cannot give any guarantees on the speed of peer-review or publication, but we aim for an average decision time of 2 months after submission for papers sent out for peer-review. There will, however, always be outliers.

Manuscript Requirements

Manuscripts should meet the following requirements: the study conducted is ethical; the material is original; the writing is clear; the study methods are appropriate; the data are valid; the conclusions are reasonable and supported by the data; the information is important; there is a clear translational focus or path to clinical application; and the topic is interesting for our readership.

Ethical Issues

If human subjects are involved, informed consent, protection of privacy and other human rights are further criteria against which the manuscript will be judged. Papers describing investigations on human subjects must include a statement that the study was approved by the institutional review board.

Types of Papers

JTEHM publishes two main types of articles, papers and challenge papers.

Papers
Download the template.
Choose this option if your paper is a research article that fits our scope. Email us if you would like us to review your abstract for fit before you submit.

Challenge Papers
Download the template.
Choose the Challenge format for case studies, industry reports, challenges to the research community. Challenge papers will be peer-reviewed but as communications more than full research papers.

Policy and Policy Proposals
Policy proposals should be based on a thorough review of the literature and stakeholder consultations, workshops or consensus building processes etc. If it is just the opinion of an individual (or small group of individuals), submit as a guest editorial or comment on our blog.

Challenges to the Community
Short evidence-based critical summaries of a current challenge in biomedical engineering or healthcare. Selection criteria for challenges discussed include one or more of the following: Issues of great potential impact on one or more groups of decision-makers in the health system. Discussion of timely or important methodological issues or problems. Illustration of new ideas or concepts that could represent food for reflection and discussion. Direct impact on ongoing translational research.

Copyright

IEEE requires authors to sign a copyright license agreement and disclosure form in case of acceptance; it is the responsibility of the first author to ensure that coauthors sign and submit the forms.

Indexing and Impact Factor

As a new journal, JTEHM is not yet indexed or rated. All papers are published in Xplore, and we are actively pursuing indexing in the major bibliographic databases and abstracting services, including Medline [Index Medicus], CINAHL, Information Science Abstracts, INSPEC (Institution of Electrical Engineers), Communication Abstracts, The Informed Librarian Online, LISA (Library and Information Science Abstracts), EMBASE, Scopus, Science Citation Index Expanded, PsycINFO, LISTA (Library / Information Sciences & Technology Abstracts), ASSIA (Applied Social Sciences Index and Abstracts) database, CSA Social Services Abstracts database, PubMed Central, and others. When we receive indexing, all published articles from inception will be indexed.

Editorial Board Policy

Purpose: The Editorial Board is a group of outstanding individuals committed to helping JTEHM produce an excellent multidisciplinary scientific publication of the highest quality. Editorial Board members are appointed by the editors-in-chief for a 3-year term that is renewable. Nominations for Editorial Board appointments come from a variety of sources including self-nominations, the current Editorial Board, journal authors, and readers. The Editorial Board aims to constitute an appropriate interdisciplinary mix from a wide range of disciplines, including health care researchers, researchers from the engineering sciences, social sciences, industry, practicing clinicians, and student representatives on our Junior Associate Editorial Board. Our board members are productive and highly respected members of the scientific and industry communities.

We are not currently seeking any new editorial board members.

Subscribe to RSS Feeds

Use your favorite newsreader or live bookmarks to stay abreast of the latest research published in JTEHM. Copy this link, also found in the Latest News icon above, and paste it into your newsreader’s Add Feed function. Refer to your newsreader’s instructions for further help.

Publication Fees Policy

As we aim to publish widely indexed, carefully copyedited, high-quality manuscripts that are also deposited in repositories such as PubMed Central, publication of an accepted paper requires expensive production steps such as copyediting, reference checking and XML tagging. In the editing and production stage, IEEE employs professional full-time staff and freelancers, and we have to pay for these services. To defray these costs (and because we do not sell subscriptions like toll-access journals) we require authors to pay certain fees.

Authors publishing in JTEHM pay an article processing fee open access fee (also called an open access, or OA fee) of $1750 only in case of acceptance.

These fees are usually funded from research grants, and new researchers in the area are urged to budget for open access publications in their grant proposals, much as they budget for conference presentations.

When comparing the cost of publishing in JTEHM against the cost of publishing in other OA journals, please consider that 1) IEEE journals’ reputation for quality, and 2) JTEHM employs professional copyediting after acceptance, which is a service many OA journals with lower costs do not provide. Given these considerations, JTEHM is currently one of the most cost-effective OA journals on the market.

Article processing fees for Open Access journals have become an increasingly accepted method to defray the costs for publication, and fortunately most institutions have developed mechanisms and funding sources to cover publication costs in high-quality open access journals.

Instructions for Authors

Submit articles for publication in JTEHM through Manuscript Central. All submissions must follow the IEEE JTEHM templates. Upon acceptance, authors are encouraged to include either a video abstract or a high-resolution image for both Xplore and JTEHM.

Interactive Content

JTEHM welcomes comments and guest blogs from the translational engineering community. Comments are moderated, so there will be a short lag before comments are posted. All papers are encouraged to include video, tutorials, interactive content, and high-resolution images as well.

Scope Statement

We focus on innovative solutions to healthcare needs from biomedical engineering, clinical engineering, and medical communities that bridge the engineering and clinical worlds. JTEHM's unique scope is original work at the intersection of engineering and clinical translation.

The journal’s focus is interdisciplinary collaborations among researchers, healthcare providers, and industry. We publish results and best practices from these translational efforts and serve as a community hub for researchers, clinicians, and developers who are addressing challenges in technology development, commercialization, and deployment for better global healthcare. Our ultimate goal is to improve the practice of engineering in translational medicine and to serve as a focal point for the nascent community. Our interactive content includes video, lively commentary, blogs, and other features to engage our clinical and engineering communities.